Chlorpromazine Hydrochloride NDC 70518-3952

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3952Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3952Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3952-1	70518395201	100 POUCH in 1 BOX (70518-3952-1) / 1 TABLET, FILM COATED in 1 POUCH (70518-3952-2)Marketed from Sep 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorpromazine Hydrochloride
Generic name (nonproprietary): chlorpromazine hydrochloride
Active ingredients: Chlorpromazine hydrochloride — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 084112
Marketing start: Dec 11, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 70518-3952_5a6b555e-161f-a9a6-e063-6294a90ab9f2SPL ID 5a6b555e-161f-a9a6-e063-6294a90ab9f2SPL set ID a2ca3aa1-9e3b-4eca-af26-165562cee7bcRxCUI 991194UNII 9WP59609J6
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518395201 followed by a unit qualifier and the quantity

Package 70518-3952-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanyi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 084112

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 084112
Product	Strength	Form · route	Labeler	Product NDC
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 25 mg/1	Tablet, Film coatedOral	Upsher-Smith Laboratories, LLC	0832-6018